Celorb Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
Celorb General Information
Description
Developer of advanced human tissue models designed to evaluate both therapeutic effectiveness and lung toxicity on a single platform. The company's platform offers to combine patient-derived cancer and immune cells with engineered scaffolds, enabling cancer drug developers for predictive preclinical insights compared to traditional rodent or organoid models.
Contact Information
Corporate Office
- Atlanta, GA
- United States
Corporate Office
- Atlanta, GA
- United States
Celorb Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 25-Jun-2026 | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2024 | Completed | Startup |
Celorb Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Biolocity | Accelerator/Incubator | Minority | ||
| CREATE-X | Accelerator/Incubator |
Celorb FAQs
-
Where is Celorb headquartered?
Celorb is headquartered in Atlanta, GA.
-
What industry is Celorb in?
Celorb’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Celorb a private or public company?
Celorb is a Private company.
-
What is Celorb’s current revenue?
The current revenue for Celorb is .
-
Who are Celorb’s investors?
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process